Gilead Sciences (GILD) Prepaid Assets (2009 - 2026)
Gilead Sciences posted quarterly Prepaid Assets of $4.3 billion for Q1 2026, up 53.54% year-on-year from $2.8 billion in Q1 2025, and up 7.9% on a QoQ basis from $4.0 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Prepaid Assets data on file, last reported at $4.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 53.54% year-over-year to $4.3 billion; the trailing twelve-month figure through Mar 2026 stood at $4.3 billion (up 53.54% YoY), and the FY2025 full-year result was $4.0 billion, up 31.85% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.3 billion, up from $4.0 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.3 billion in Q1 2026 and bottomed at $1.8 billion in Q2 2023.
- The 5-year median for Prepaid Assets is $2.8 billion (2024), against an average of $2.7 billion.
- The widest annual swing landed in 2022, when Prepaid Assets fell 17.14%; it then soared 62.55% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $1.8 billion in 2022, then jumped by 33.82% to $2.4 billion in 2023, then rose by 28.56% to $3.1 billion in 2024, then jumped by 31.85% to $4.0 billion in 2025, then climbed by 7.9% to $4.3 billion in 2026.
- The last three Prepaid Assets figures came in at $4.3 billion (Q1 2026), $4.0 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.34 Bn |
| Dec 31, 2025 | 4.02 Bn |
| Sep 30, 2025 | 3.65 Bn |
| Jun 30, 2025 | 2.90 Bn |
| Mar 31, 2025 | 2.83 Bn |
| Dec 31, 2024 | 3.05 Bn |
| Sep 30, 2024 | 3.29 Bn |
| Jun 30, 2024 | 2.86 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 2.37 Bn |
| Sep 30, 2023 | 2.66 Bn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 2.08 Bn |
| Jun 30, 2022 | 1.90 Bn |
| Mar 31, 2022 | 2.04 Bn |
| Dec 31, 2021 | 2.14 Bn |
| Sep 30, 2021 | 2.01 Bn |
| Jun 30, 2021 | 1.48 Bn |
| Mar 31, 2021 | 1.91 Bn |
| Dec 31, 2020 | 2.01 Bn |
| Sep 30, 2020 | 2.03 Bn |
| Jun 30, 2020 | 1.48 Bn |
| Mar 31, 2020 | 1.27 Bn |
| Dec 31, 2019 | 1.44 Bn |
| Sep 30, 2019 | 1.31 Bn |
| Jun 30, 2019 | 2.26 Bn |
| Mar 31, 2019 | 1.94 Bn |
| Dec 31, 2018 | 9.00 Mn |
| Sep 30, 2018 | 2.17 Bn |
| Jun 30, 2018 | 2.41 Bn |
| Mar 31, 2018 | 1.60 Bn |
| Dec 31, 2017 | 1.66 Bn |
| Sep 30, 2017 | 1.66 Bn |
| Jun 30, 2017 | 1.61 Bn |
| Mar 31, 2017 | 1.80 Bn |
| Dec 31, 2016 | 1.59 Bn |
| Sep 30, 2016 | 1.42 Bn |
| Jun 30, 2016 | 1.15 Bn |
| Mar 31, 2016 | 2.08 Bn |
| Dec 31, 2015 | 1.52 Bn |
| Sep 30, 2015 | 490.00 Mn |
| Jun 30, 2015 | 282.00 Mn |
| Mar 31, 2015 | 236.00 Mn |
| Dec 31, 2014 | 1.06 Bn |
| Sep 30, 2014 | 599.12 Mn |
| Jun 30, 2014 | 232.15 Mn |
| Mar 31, 2014 | 201.01 Mn |
| Dec 31, 2013 | 91.00 Mn |
| Sep 30, 2013 | 462.70 Mn |
| Jun 30, 2013 | 176.36 Mn |
| Mar 31, 2013 | 411.12 Mn |
| Dec 31, 2012 | 102.36 Mn |
| Sep 30, 2012 | 334.01 Mn |
| Jun 30, 2012 | 226.90 Mn |
| Mar 31, 2012 | 175.63 Mn |
| Dec 31, 2011 | 246.44 Mn |
| Sep 30, 2011 | 90.82 Mn |
| Jun 30, 2011 | 85.02 Mn |
| Mar 31, 2011 | 96.08 Mn |
| Dec 31, 2010 | 67.63 Mn |
| Sep 30, 2010 | 78.70 Mn |
| Mar 31, 2010 | 79.90 Mn |
| Dec 31, 2009 | 78.11 Mn |
| Sep 30, 2009 | 83.39 Mn |
| Jun 30, 2009 | 78.55 Mn |